In this section
General requirements for all applications
- Assessment templates and guidance
- Clinical data publication
- Compliance: marketing authorisation
- Data on medicines (ISO IDMP standards): marketing authorisation
- Fees payable to the European Medicines Agency
- Marketing authorisation guidance documents
- Obtaining an EU marketing authorisation, step-by-step
- Pharmacovigilance: marketing authorisation
- Pre-authorisation guidance
- Product-information requirements
- Submission dates
- The evaluation of medicines, step-by-step
Particular application types
- Accelerated assessment
- Advanced therapies: marketing authorisation
- Biosimilar medicines: marketing authorisation
- Conditional marketing authorisation
- Generic and hybrid applications
- Medicines for use outside the European Union
- Orphan designation: marketing authorisation
- Paediatric medicines: Marketing authorisation
Related documents
Applying for European Union marketing authorisation for medicinal products for human use
English (EN) (289.34 KB - PDF)
Procedural advice to CHMP members
English (EN) (177.89 KB - PDF)
Procedural advice on the re-examination of CHMP opinions
English (EN) (147.62 KB - PDF)
From lab to patient: journey of a medicine
Follow the journey of a medicine for human use assessed by EMA in this interactive timeline. It explains all stages from initial research to patient access, including how EMA supports medicine development, assesses the benefits and risks and monitors the safety of medicines. The full text is available as a booklet below.
From laboratory to patient: the journey of a centrally authorised medicine
English (EN) (1.76 MB - PDF)
български (BG) (4.64 MB - PDF)
español (ES) (4.79 MB - PDF)
čeština (CS) (4.61 MB - PDF)
dansk (DA) (4.66 MB - PDF)
Deutsch (DE) (4.93 MB - PDF)
eesti keel (ET) (4.75 MB - PDF)
ελληνικά (EL) (4.65 MB - PDF)
français (FR) (4.87 MB - PDF)
hrvatski (HR) (4.8 MB - PDF)
italiano (IT) (4.86 MB - PDF)
latviešu valoda (LV) (4.88 MB - PDF)
lietuvių kalba (LT) (4.68 MB - PDF)
magyar (HU) (4.69 MB - PDF)
Nederlands (NL) (4.65 MB - PDF)
polski (PL) (4.92 MB - PDF)
português (PT) (4.65 MB - PDF)
română (RO) (4.81 MB - PDF)
slovenčina (SK) (4.79 MB - PDF)
slovenščina (SL) (4.8 MB - PDF)
Suomi (FI) (4.75 MB - PDF)
svenska (SV) (4.62 MB - PDF)